World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
24819
World Ranking
17969
National Ranking
8958

Alan K. Meeker publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alan K. Meeker sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 335 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Alan K. Meeker D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alan K. Meeker sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Alan K. Meeker is affiliated with Johns Hopkins University School of Medicine in the United States. Their research encompasses a range of topics primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Subfields of study include Molecular Biology, Pulmonary and Respiratory Medicine, Physiology, Genetics, and Immunology.

Their work covers main research themes such as Telomeres, Telomerase, and Senescence; Prostate Cancer Treatment and Research; Glioma Diagnosis and Treatment; Xenotransplantation and Immune Response; Peptidase Inhibition and Analysis; Epigenetics and DNA Methylation; and Protease and Inhibitor Mechanisms.

Alan K. Meeker has published frequently in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Prostate
  • Cancer Research
  • Oncogene
  • Molecular Cancer Research

Frequent collaborators include Angelo M. De Marzo, Christopher M. Heaphy, Tamara L. Lotan, Corinne E. Joshu, and William G. Nelson.

Notable recent publications include:

  • Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors (2020, Oncogene)
  • ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization (2022, Cell Reports)
  • Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer (2021, JCI Insight)
  • Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer (2021, Proceedings of the National Academy of Sciences)
  • LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance (2022, ImmunoHorizons)

Best Publications

  • TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

    Patrick J. Killela;Zachary J. Reitman;Yuchen Jiao;Chetan Bettegowda

  • Altered Telomeres in Tumors with ATRX and DAXX Mutations

    Christopher M. Heaphy;Roeland F. de Wilde;Yuchen Jiao;Alison P. Klein

  • Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements

    Michael C Haffner;Martin J Aryee;Antoun Toubaji;David M Esopi

  • Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.

    Yuchen Jiao;Patrick J. Killela;Zachary J. Reitman;B Ahmed Rasheed

  • Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.

    Courtney A. Lovejoy;Wendi Li;Steven Reisenweber;Supawat Thongthip

  • Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

    Christopher M. Heaphy;Andrea P. Subhawong;Seung Mo Hong;Michael G. Goggins

  • Telomerase activity: a prevalent marker of malignant human prostate tissue.

    Hans Joerg Sommerfeld;Alan K. Meeker;Mieczyslaw A. Piatyszek;G. Steven Bova

  • Contributions of the large hydrophobic amino acids to the stability of staphylococcal nuclease

    David Shortle;Wesley E. Stites;Alan K. Meeker

  • Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing

    Karen Sandell Sfanos;Tullia C. Bruno;Charles H. Maris;Lauren Xu

  • Tracking the clonal origin of lethal prostate cancer.

    Michael C. Haffner;Timothy Mosbruger;David M. Esopi;Helen Fedor

  • Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers

    Michael C Haffner;Alcides Chaux;Alan K. Meeker;David M Esopi

  • TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL

    Hai Yan;P.J. Killela;Z.J. Reitman;Y. Jiao

  • Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.

    N. Tjarda van Heek;N. Tjarda van Heek;Alan K. Meeker;Scott E. Kern;Charles J. Yeo

  • Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis.

    Alan K. Meeker;Jessica L. Hicks;Christine A. Iacobuzio-Donahue;Elizabeth A. Montgomery

  • Mutant forms of staphylococcal nuclease with altered patterns of guanidine hydrochloride and urea denaturation.

    David Shortle;Alan K. Meeker

  • Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition

    Lynnette R. Ferguson;Helen Chen;Andrew R. Collins;Marisa Connell

  • Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.

    Karen S. Sfanos;Tullia C. Bruno;Alan K. Meeker;Alan K. Meeker;Angelo M. De Marzo;Angelo M. De Marzo

  • PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas

    Ashley Cimino-Mathews;Elizabeth Thompson;Janis M. Taube;Xiaobu Ye

  • Residual structure in large fragments of staphylococcal nuclease: effects of amino acid substitutions.

    David Shortle;Alan K. Meeker

  • Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis

    Alan K Meeker;Jessica L Hicks;Elizabeth A Platz;Gerrun E March

Frequent Co-Authors

Angelo M. De Marzo
Angelo M. De Marzo Johns Hopkins University School of Medicine
George J. Netto
George J. Netto University of Alabama at Birmingham
Elizabeth A. Platz
Elizabeth A. Platz Johns Hopkins University
William G. Nelson
William G. Nelson Johns Hopkins University School of Medicine
Pedram Argani
Pedram Argani Johns Hopkins University
William B. Isaacs
William B. Isaacs Johns Hopkins University
Charles G. Eberhart
Charles G. Eberhart Johns Hopkins University School of Medicine
Charles G. Drake
Charles G. Drake Columbia University
Ralph H. Hruban
Ralph H. Hruban Johns Hopkins University School of Medicine
Srinivasan Yegnasubramanian
Srinivasan Yegnasubramanian Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical degree in the USA can open doors to a variety of related fields and advanced career options. If you’re looking for healthcare roles beyond traditional medicine, numerous online study paths may suit your interests and professional goals.

Managing healthcare facilities has become a key area of demand. Earning a health care administration degree online lets students develop management expertise and prepare for leadership roles without disrupting their current commitments. For those who wish to specialize further, exploring the most affordable online mha programs can make advanced education more accessible while preparing graduates for high-level administrative positions.

Advanced clinical roles are also growing in popularity. Prospective nurse leaders can consider the cheapest dnp programs online to earn the Doctor of Nursing Practice, a top credential for clinical expertise. For those interested in pharmacy, online pharm d programs make it possible to become a licensed pharmacist through flexible, accredited study options.

Best Scientists Citing Alan K. Meeker

Trending Scientists

Recently Published Articles